Business Context and Reporting Period
Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 15, 2016
Event: Regulation FD Disclosure (Item 7.01) regarding the preparation of presentation materials for use with investors, brokers, lenders, and other stakeholders.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of presentation materials and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is procedural, intended to make presentation materials available to the public to comply with Regulation FD.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to use the attached presentation materials (Exhibit 99.1) in presentations to various stakeholders.
- Outlook: The materials speak as of January 15, 2016. The Company disclaims any obligation to update the materials to reflect future events or circumstances.
- Risks/Contingencies: The information is "furnished" and not "filed" under Section 18 of the Securities Exchange Act of 1934, meaning it is not subject to the liabilities of that section. It shall not be incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of the presentation materials attached as Exhibit 99.1, which are not included in the text of this 8-K.
- Confirm that the presentation materials are posted on the Company's Investor Relations website (www.biorestorative.com) for 90 days.
- Note that the Company explicitly disclaims any obligation to update the information contained in the presentation materials after the report date.
- Recognize that this filing does not constitute a formal filing of financial data under Section 18 of the Exchange Act.